Extensions

Patent Term and Related Applications for U.S. Patent No. 12,254,103

As of May 1, 2026, the following details pertain to the term, application history, and international family of U.S. Patent No. 12,254,103.

Patent Term Adjustment (PTA) and Projected Expiration

A patent's term is typically 20 years from the earliest effective U.S. non-provisional filing date. For U.S. Patent No. 12,254,103, this would normally result in an expiration date of September 25, 2040, which is 20 years from its filing date of September 25, 2020.

However, the USPTO has granted a Patent Term Adjustment (PTA) to compensate for administrative delays during the patent prosecution process. The official "Adjusted expiration" date for this patent is listed as June 24, 2041.

This indicates a total PTA of 272 days. The adjustment extends the patent's enforceability beyond the standard 20-year term. There is no indication of any Patent Term Extension (PTE) under 35 U.S.C. § 156, which typically applies to products requiring pre-market regulatory review, such as pharmaceuticals.

Application History

• Application Number: The patent was granted from U.S. application number 17/767,153.
• Continuations and Divisionals: This application is the U.S. national stage entry of an international PCT application. It is not a continuation or divisional application of a prior U.S. patent application.

Patent Family and Priority

U.S. Patent No. 12,254,103 is part of a larger international patent family, claiming priority to an initial European patent application. This establishes an invention priority date of October 18, 2019.

• Priority Application:

  • EP19306357: Filed in the European Patent Office on October 18, 2019.

• International (PCT) Application:

  • WO2021073853A1 (filed as PCT/EP2020/076906): This international application was filed on September 25, 2020, and designated multiple countries for patent protection.

• Known National Family Members:
  Based on the priority claim, the following corresponding patents or patent applications have been filed in other jurisdictions:

  • Australia: AU2020367942A1
  • Brazil: BR112022006930A2
  • Canada: CA3154428A1
  • China: CN114868147B
  • Europe: EP3809358A1
  • South Korea: KR102822481B1